Showing results (151-160 of 264) with videos related to
Sort By:
Pageof 27
Molecular Psychiatry|June 15, 2018
Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune statesW Kyle Simmons, Kaiping Burrows, Jason A Avery, et al.Psychiatry Research|February 22, 2012
Baseline mood-state measures as predictors of antidepressant response to scopolamineMaura L Furey, Allison C Nugent, Andrew M Speer, et al.Molecular Psychiatry|October 17, 2022
Genome-wide association study meta-analysis of suicide death and suicidal behaviorQingqin S Li, Andrey A Shabalin, Emily DiBlasi, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2024
Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled studyMatthew E Klein, Abigail Bangerter, Robin J Halter, et al.The Journal of Clinical Psychiatry|April 25, 2009
A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patientsGregory J Moore, Bernadette M Cortese, Debra A Glitz, et al.The Journal of Clinical Psychiatry|May 16, 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)Dong-Jing Fu, Dawn F Ionescu, Xiang Li, et al.Journal of Affective Disorders|June 16, 2021
A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressantsJennifer Bogert, Hany Rofael, Kenneth Mosca, et al.The International Journal of Neuropsychopharmacology|August 30, 2020
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)Dawn F Ionescu, Dong-Jing Fu, Xin Qiu, et al.Brain Structure & Function|June 11, 2017
Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disordersHao He, Jing Sui, Yuhui Du, et al.Translational Psychiatry|October 6, 2018
Altered cerebral benzodiazepine receptor binding in post-traumatic stress disorderInbal Reuveni, Allison C Nugent, Jessica Gill, et al.Pageof 27